Gene therapy in rheumatoid arthritis: how to target joint destruction?

This publication has 34 references indexed in Scilit:

• Direct evidence of high DNA binding activity of transcription factor AP‐1 in rheumatoid arthritis synovium
  Arthritis & Rheumatism, 1997
• The AP-1 site and MMP gene regulation: What is all the fuss about?
  Matrix Biology, 1997
• TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis
  APMIS, 1997
• The role of VCAM-1 molecule in the pathogenesis of rheumatoid synovitis.
  1996
• Constitutive expression of c-fos and c-jun, overexpression of ets-2, and reduced expression of metastasis suppressor gene nm23-H1 in rheumatoid arthritis.
  Annals of the Rheumatic Diseases, 1996
• ONCOGENES IN RHEUMATOID ARTHRITIS
  Rheumatic Disease Clinics of North America, 1995
• Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis
  Arthritis & Rheumatism, 1995
• Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry.
  1995
• Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes.
  1992
• Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts
  Rheumatology International, 1992